Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis.
Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey.
Temporal Hierarchical Adaptive Texture CRF for Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI.
Will Biomarkers Determine What Is Next in Multiple Sclerosis?: Biomarkers in Multiple Sclerosis.
Laparoscopic implantation of neuromodulators for treating urinary dysfunctions and improving locomotion in multiple sclerosis patients.
[Treatment of transplantation of NT-3 gene modified olfactory ensheathing cells on experimental autoimmune encephalomyelitis in rats].
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
Environmental factors acting during development to influence MS risk: insights from animal studies.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Neuromyelitis optica antibody in Leber hereditary optic neuropathy: case report.
Myocarditis and diffuse skeletal muscle oedema: new features of neuromyelitis optica spectrum disorder? A case report.
Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis.
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab.
Habitual Functional Electrical Stimulation Therapy Improves Gait Kinematics and Walking Performance, but Not Patient-Reported Functional Outcomes, of People with Multiple Sclerosis who Present with Foot-Drop.
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
Interferon-β-1a-induced psychosis in a patient with multiple sclerosis.
Quality of life and employment in persons with multiple sclerosis.
Multiple sclerosis: Insights into pathophysiology and novel therapeutic avenues.
Ascl1/Mash1 Promotes Brain Oligodendrogenesis during Myelination and Remyelination.
Chemokine receptor expression of T cells in the cerebrospinal fluid of relapsing multiple sclerosis.
Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis.
RECENT ADVANCES IN MESENCHYMAL STEM CELL IMMUNOMODULATION. THE ROLE OF MICROVESICLES.
Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells.

Pages